ICD CSD
Sanofi
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
127
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
0
PubMed author-name match
Trials
Studies that name ICD CSD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:27 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT00913614 · Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With InsomniaSanofi · completed · Sleep Initiation and Maintenance Disorders · study director
- Ph3NCT00855530 · Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive DisorderSanofi · completed · Major Depressive Disorders · study director
- Ph3NCT00825019 · Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and ParoxetineSanofi · completed · Major Depressive Disorders · study director
- Ph3NCT00825058 · Efficacy and Safety of SR58611 Compared to Placebo and ParoxetineSanofi · completed · Major Depressive Disorders · study director
- Ph3NCT00805350 · Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance DifficultiesSanofi · completed · Primary Insomnia · study director
- Ph2NCT00798005 · Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease.Sanofi · completed · Severe Peripheral Artery Occlusive Disease · study director
- Ph3NCT00788515 · Comparison of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance DifficultiesSanofi · terminated · Sleep Initiation and Maintenance Disorders · study director
- Ph3NCT00766688 · Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing High Doses of Statins in Patients With Primary Severe HypercholesterolemiaSanofi · terminated · Hypercholesterolemia · study director
- Ph3NCT00754689 · Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 DiabetesSanofi · withdrawn · Diabetes Mellitus, Type 2 · study director
- Ph2NCT00739206 · Study of SAR97276A in the Treatment of Uncomplicated and Severe Malaria in Adults and Children.Sanofi · terminated · Malaria · study director
- Ph3NCT00728091 · A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional HyponatremiaSanofi · terminated · Hyponatremia, Inappropriate ADH Syndrome · study director
- Ph2NCT00723086 · Japanese Study of the Combined Administration of Docetaxel With Prednisolone for Metastatic Hormone Refractory Prostate CancerSanofi · completed · Therapy, Prostatic Neoplasms · study director
- Ph3NCT00690456 · Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 DiabetesSanofi · terminated · Diabetes Mellitus, Type 2 · study director
- Ph3NCT00685958 · Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture SurgerySanofi · completed · Hip Fractures · study director
- Ph3NCT00629551 · An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive DisorderSanofi · completed · Depressive Disorder, Major · study director
- Ph3NCT00630175 · Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary InsomniaSanofi · completed · Sleep Initiation and Maintenance Disorders · study director
- Ph3NCT00577148 · An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 DiabetesSanofi · terminated · Fatty Liver · study director
- Ph3NCT00576823 · Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic EtiologySanofi · completed · Hydronephrosis, Neurogenic Bladder · study director
- Ph3NCT00576667 · An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without DiabetesSanofi · terminated · Fatty Liver · study director
- Ph3NCT00566657 · Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin LesionsSanofi · completed · Peripheral Vascular Diseases · study director
- Ph2NCT00564226 · SSR240600C Treatment in Women With Overactive BladderSanofi · completed · Overactive Bladder · study director
- Ph3NCT00549939 · Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder DysfunctionSanofi · completed · Neurogenic Urinary Bladder · study director
- Ph1NCT00547261 · Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory CancerSanofi · terminated · Neoplasms · study director
- Ph1NCT00543972 · Dose Escalation Safety and Pharmacokinetic Study of AVE9633 as Single Agent in Relapsed/Refractory CD33-Positive Acute Myeloid LeukemiaSanofi · terminated · Myeloid Leukemia · study director
- Ph3NCT00535340 · An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Generalized Anxiety DisorderSanofi · terminated · Anxiety Disorders · study director
- Ph2NCT00502515 · Dose-effect of SSR180575 in Diabetic NeuropathySanofi · completed · Diabetic Neuropathies · study director
- Ph2NCT00501384 · Satavaptan Dose-Ranging Study in the Prevention of AscitesSanofi · completed · Ascites, Liver Cirrhosis · study director
- Ph2NCT00501722 · Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic AscitesSanofi · completed · Ascites, Liver Cirrhosis · study director
- Ph3NCT00495885 · Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes MellitusSanofi · completed · Sleep Initiation and Maintenance Disorders · study director
- Ph3NCT00481975 · Efficacy and Safety of Rimonabant on Weight Loss and Frequency of Binge Episodes in Obese PatientsSanofi · completed · Obesity, Eating Disorders · study director
- Ph3NCT00478972 · Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and ExerciseSanofi · terminated · Obesity, Diabetes Mellitus Type 2 · study director
- Ph3NCT00478595 · Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic DrugSanofi · terminated · Obesity, Diabetes Mellitus Type 2 · study director
- Ph2NCT00475865 · Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple SclerosisSanofi · completed · Multiple Sclerosis · study director
- Ph3NCT00464243 · Efficacy and Safety of Volinanserin on Sleep Maintenance Insomnia - Polysomnographic StudySanofi · completed · Sleep Initiation and Maintenance Disorders · study director
- Ph3NCT00464061 · Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes MellitusSanofi · terminated · Sleep Initiation and Maintenance Disorders · study director
- Ph3NCT00458718 · Efficacy and Safety of Rimonabant as an Aid to Smoking Cessation With or Without Nicotine PatchSanofi · completed · Smoking Cessation · study director
- Ph3NCT00459173 · Efficacy and Safety of Rimonabant as an Aid to Maintenance of Smoking CessationSanofi · completed · Maintenance of Smoking Cessation · study director
- Ph2NCT00440154 · A Study Evaluating the Safety and Efficacy of AVE5530 (4 Weeks) in Patients With Mild to Moderate HypercholesterolemiaSanofi · completed · Hypercholesterolemia · study director
- Ph2NCT00439634 · Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in SchizophreniaSanofi · terminated · Schizophrenia · study director
- Ph3NCT00434096 · Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS)Sanofi · terminated · Obesity · study director
- Ph3NCT00432614 · Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive DisorderSanofi · completed · Major Depressive Disorder · study director
- Ph3NCT00425243 · Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG)Sanofi · completed · Sleep Initiation and Maintenance Disorders · study director
- Ph2NCT00409357 · Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic HyperplasiaSanofi · completed · Benign Prostatic Hyperplasia · study director
- Ph3NCT00399464 · Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic HyperplasiaSanofi · completed · Prostatic Hyperplasia · study director
- Ph3NCT00397098 · Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety DisorderSanofi · terminated · Anxiety Disorders · study director
- Ph3NCT00386061 · Rimonabant in Obesity Over a 2-Year Duration (RIO-Europe)Sanofi · completed · Obesity · study director
- Ph4NCT00386191 · Safety and Efficacy of Clopidogrel for Cerebral Infarction TreatmentSanofi · completed · Cerebral Infarction · study director
- Ph3NCT00385307 · Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS)Sanofi · completed · Major Depressive Disorder · study director
- Ph1/Ph2NCT00380302 · Activity of AVE1625 in Mild to Moderate Alzheimer's Patients.Sanofi · completed · Alzheimer Disease · study director
- Ph3NCT00366795 · Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the LiverSanofi · terminated · Ascites, Liver Cirrhosis · study director
- Ph2NCT00361491 · An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive DisorderSanofi · completed · Depressive Disorder · study director
- Ph3NCT00359437 · Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the LiverSanofi · terminated · Ascites, Liver Cirrhosis · study director
- Ph2NCT00358631 · An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive DisorderSanofi · completed · Depressive Disorder · study director
- Ph3NCT00358176 · Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal WomenSanofi · completed · Osteoporosis Postmenopausal · study director
- Ph3NCT00356967 · Efficacy and Safety of Dianicline Versus Placebo as an Aid to Smoking CessationSanofi · completed · Smoking · study director
- Ph3NCT00347061 · Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPHSanofi · completed · Benign Prostatic Hyperplasia · study director
- Ph3NCT00345618 · Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic ApproachSanofi · completed · Embolism, Thrombosis · study director
- Ph3NCT00345098 · A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive DisorderSanofi · completed · Depressive Disorder, Major Depression · study director
- Ph3NCT00332891 · An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety DisorderSanofi · completed · Anxiety Disorders · study director
- Ph2NCT00327171 · Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian CancerSanofi · completed · Neoplasms, Cancer of the Ovary · study director
- Ph3NCT00325546 · Study of Weight-Reducing Effect and Safety of Rimonabant In Obesity in ASIA (RIO-ASIA)Sanofi · completed · Obesity · study director
- Ph3NCT00325650 · Rimonabant In Prediabetic Subjects To Delay Onset Of Type 2 DiabetesSanofi · terminated · Prediabetic State · study director
- Ph3NCT00319709 · An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With DepressionSanofi · completed · Depressive Disorder · study director
- Ph3NCT00318448 · Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated InsomniaSanofi · completed · Attention Deficit Hyperactivity Disorder · study director
- Ph2NCT00317395 · Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary SyndromeSanofi · completed · Coronary Disease · study director
- Ph3NCT00315549 · TELI TAD - Telithromycin in Tonsillitis in Adolescents and AdultsSanofi · terminated · Tonsillitis, Pharyngitis · study director
- Ph3NCT00315003 · TELI COM - Telithromycin in Children With Otitis MediaSanofi · terminated · Otitis Media, Suppurative, Otitis Media, Purulent · study director
- Ph2NCT00313885 · Efficacy and Safety of SR46349B in Patients With Sleep Disorders in FibromyalgiaSanofi · completed · Fibromyalgia, Sleep, Chronic Pain · study director
- Ph3NCT00311090 · Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower LimbsSanofi · completed · Deep Venous Thrombosis · study director
- Ph3NCT00308503 · Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance InsomniaSanofi · completed · Sleep Initiation and Maintenance Disorders, Insomnia · study director
- Ph2NCT00300339 · Mixed Antagonist of Serotonin for Claudication Optimal TherapySanofi · completed · Intermittent Claudication · study director
- Ph2NCT00299871 · Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes MellitusSanofi · completed · Type 2 Diabetes · study director
- Ph2/Ph3NCT00290953 · Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + EtoposideSanofi · completed · Lung Cancer, Pulmonary Neoplasms, Small Cell Lung Cancer · study director
- Ph3NCT00290030 · ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPHSanofi · completed · Prostatic Hyperplasia, Acute Urinary Retention · study director
- Ph3NCT00288236 · Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO)Sanofi · completed · Type 2 Diabetes Mellitus · study director
- Ph2NCT00284141 · Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung AdenocarcinomaSanofi · completed · Pulmonary Diseases, Neoplasms, Lung · study director
- Ph3NCT00266747 · An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety DisorderSanofi · completed · Anxiety Disorders · study director
- Ph3NCT00264914 · Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionSanofi · completed · Inappropriate ADH Syndrome, Hyponatremia · study director
- Ph3NCT00264927 · Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionSanofi · completed · Inappropriate ADH Syndrome, Hyponatremia · study director
- Ph3NCT00259376 · American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus RhythmSanofi · completed · Atrial Fibrillation, Atrial Flutter · study director
- Ph3NCT00257257 · Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic PatientsSanofi · completed · Type 2 Diabetes Mellitus · study director
- Ph3NCT00256113 · An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With DepressionSanofi · completed · Depressive Disorder · study director
- Ph3NCT00254956 · Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent AsthmaSanofi · completed · Respiratory Tract Diseases, Respiratory Hypersensitivity, Asthma · study director
- Ph3NCT00253903 · Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 YearSanofi · completed · Sleep Initiation and Maintenance Disorders, Insomnia · study director
- Ph3NCT00252356 · Efficacy and Safety of SR58611A in Patients With Major Depressive DisorderSanofi · completed · Major Depressive Disorder · study director
- Ph3NCT00252343 · Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety DisorderSanofi · completed · Anxiety Disorder · study director
- Ph3NCT00252330 · Efficacy and Safety of SR58611A in Patients With Major Depressive DisorderSanofi · completed · Major Depressive Disorder · study director
- Ph3NCT00250627 · An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With DepressionSanofi · completed · Depressive Disorder · study director
- Ph3NCT00239967 · An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese PatientsSanofi · completed · Dyslipidemia, Obesity · study director
- Ph2/Ph3NCT00233441 · Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/FlutterSanofi · completed · Atrial Fibrillation, Atrial Flutter · study director
- Ph2NCT00232310 · Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttErSanofi · completed · Atrial Fibrillation, Atrial Flutter · study director
- Ph2NCT00232297 · Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnSSanofi · completed · Arrhythmia, Tachycardia, Ventricular, Ventricular Fibrillation · study director
- Ph4NCT00230217 · Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor MalignancySanofi · completed · Tumors, Hyperuricemia, Tumor Lysis Syndrome · study director
- Ph3NCT00174811 · Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear InfectionsSanofi · terminated · Otitis Media · study director
- Ph2NCT00174746 · Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent AsthmaSanofi · completed · Asthma · study director
- Ph3NCT00174720 · Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid.Sanofi · completed · Asthma · study director
- Ph3NCT00174837 · TRACE: Tirapazamine-Radiation And Cisplatin EvaluationSanofi · completed · Head and Neck Squamous Cell Carcinoma · study director
- Ph3NCT00174733 · Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled CorticosteroidSanofi · completed · Asthma · study director
- Ph4NCT00174824 · Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic PatientsSanofi · completed · Diabetes Mellitus, Type 2 · study director
- Ph2NCT00133731 · The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary InterventionSanofi · completed · Angioplasty, Transluminal, Percutaneous Coronary · study director
- Ph3NCT00124332 · STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)Sanofi · completed · Coronary Atherosclerosis · study director
- Ph2NCT00123565 · Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial InfarctionSanofi · completed · Coronary Atherosclerosis · study director
- Ph2NCT00115375 · Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)Sanofi · completed · Congenital Heart Defects, Blood Platelet Disorders · study director
- Ph3NCT00104013 · Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's TypeSanofi · completed · Alzheimer Disease · study director
- Ph3NCT00103649 · 18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's TypeSanofi · completed · Alzheimer Disease · study director
- Ph2NCT00094965 · Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal FunctionSanofi · completed · Gastrointestinal Cancer · study director
- Ph3NCT00094081 · Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck CancerSanofi · completed · Head and Neck Neoplasms · study director
- Ph2NCT00093275 · HP184 in Chronic Spinal Cord Injury SubjectsSanofi · completed · Spinal Cord Injury · study director
- Ph2NCT00087958 · Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine TreatmentSanofi · completed · Breast Cancer · study director
- Ph3NCT00081796 · Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast CancerSanofi · completed · Breast Cancer, Metastases · study director
- Ph3NCT00077792 · Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)Sanofi · completed · Myocardial Infarction, Acute ST-Segment Elevation · study director
- Ph3NCT00071279 · SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein ThrombosisSanofi · completed · Pulmonary Embolism, Deep Vein Thrombosis · study director
- Ph3NCT00070655 · Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)Sanofi · completed · Atrial Fibrillation · study director
- Ph3NCT00067093 · Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)Sanofi · completed · Deep Vein Thrombosis · study director
- Ph3NCT00062803 · SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary EmbolismSanofi · completed · Pulmonary Embolism · study director
- Ph3NCT00050817 · Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)Sanofi · completed · Arteriosclerosis · study director
- Ph3NCT00046150 · 12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.Sanofi · completed · Diabetes, Type I · study director
- Ph3NCT00045955 · Long-Term Safety Performance of Fexofenadine in AsthmaSanofi · completed · Asthma · study director
- Ph3NCT00044811 · Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent AsthmaSanofi · completed · Asthma · study director
- Ph3NCT00044824 · Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent AsthmaSanofi · completed · Asthma · study director
- Ph3NCT00044447 · Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & ThiazolidinedioneSanofi · completed · Diabetes Mellitus, Non-Insulin-Dependent · study director
- Ph2NCT00032747 · Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).Sanofi · completed · Chronic Heart Failure · study director
- Ph2NCT00032734 · Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionSanofi · completed · Syndrome of Inappropriate ADH (SIADH) Secretion, Hyponatremia · study director
- Ph3NCT00029861 · Obese Patients With or Without Comorbidities (RIO-North America)Sanofi · completed · Obesity, Weight Loss · study director
- Ph3NCT00029822 · Clinical Trial in Males With BPH (Enlarged Prostate)Sanofi · completed · Urinary Retention, Prostatic Hyperplasia, Benign Prostatic Hypertrophy · study director
- Ph3NCT00029848 · Obese Patients With Type 2 DiabetesSanofi · completed · Obesity, Diabetes Mellitus, Non-Insulin-Dependent, Obesity in Diabetes · study director
- Ph3NCT00029835 · Obese Patients With Untreated DyslipidemiasSanofi · completed · Obesity, Dyslipidemia · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.